These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 25169075)

  • 1. Manufacturing scale-up of electrospun poly(vinyl alcohol) fibers containing tenofovir for vaginal drug delivery.
    Krogstad EA; Woodrow KA
    Int J Pharm; 2014 Nov; 475(1-2):282-91. PubMed ID: 25169075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of multipurpose prevention drug combinations from electrospun nanofibers using composite microarchitectures.
    Blakney AK; Krogstad EA; Jiang YH; Woodrow KA
    Int J Nanomedicine; 2014; 9():2967-78. PubMed ID: 24971008
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased Dapivirine tissue accumulation through vaginal film codelivery of dapivirine and Tenofovir.
    Akil A; Devlin B; Cost M; Rohan LC
    Mol Pharm; 2014 May; 11(5):1533-41. PubMed ID: 24693866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durable protection from vaginal simian-human immunodeficiency virus infection in macaques by tenofovir gel and its relationship to drug levels in tissue.
    Dobard C; Sharma S; Martin A; Pau CP; Holder A; Kuklenyik Z; Lipscomb J; Hanson DL; Smith J; Novembre FJ; García-Lerma JG; Heneine W
    J Virol; 2012 Jan; 86(2):718-25. PubMed ID: 22072766
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative evaluation of a hydrophilic matrix intravaginal ring for the sustained delivery of tenofovir.
    Clark JT; Johnson TJ; Clark MR; Nebeker JS; Fabian J; Tuitupou AL; Ponnapalli S; Smith EM; Friend DR; Kiser PF
    J Control Release; 2012 Oct; 163(2):240-8. PubMed ID: 22981701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a combination microbicide gel formulation containing IQP-0528 and tenofovir for the prevention of HIV infection.
    Ham AS; Ugaonkar SR; Shi L; Buckheit KW; Lakougna H; Nagaraja U; Gwozdz G; Goldman L; Kiser PF; Buckheit RW
    J Pharm Sci; 2012 Apr; 101(4):1423-35. PubMed ID: 22227864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formulation and characterization of polymeric films containing combinations of antiretrovirals (ARVs) for HIV prevention.
    Akil A; Agashe H; Dezzutti CS; Moncla BJ; Hillier SL; Devlin B; Shi Y; Uranker K; Rohan LC
    Pharm Res; 2015 Feb; 32(2):458-68. PubMed ID: 25079391
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simultaneous delivery of tenofovir and acyclovir via an intravaginal ring.
    Moss JA; Malone AM; Smith TJ; Kennedy S; Kopin E; Nguyen C; Gilman J; Butkyavichene I; Vincent KL; Motamedi M; Friend DR; Clark MR; Baum MM
    Antimicrob Agents Chemother; 2012 Feb; 56(2):875-82. PubMed ID: 22123689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic activity of tenofovir and nevirapine combinations released from polycaprolactone matrices for potential enhanced prevention of HIV infection through the vaginal route.
    Dang NT; Sivakumaran H; Harrich D; Shaw PN; Davis-Poynter N; Coombes AG
    Eur J Pharm Biopharm; 2014 Oct; 88(2):406-14. PubMed ID: 24887313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Safety and pharmacokinetics of intravaginal rings delivering tenofovir in pig-tailed macaques.
    Moss JA; Malone AM; Smith TJ; Butkyavichene I; Cortez C; Gilman J; Kennedy S; Kopin E; Nguyen C; Sinha P; Hendry RM; Guenthner P; Holder A; Martin A; McNicholl J; Mitchell J; Pau CP; Srinivasan P; Smith JM; Baum MM
    Antimicrob Agents Chemother; 2012 Nov; 56(11):5952-60. PubMed ID: 22964245
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Electrospun fibers for vaginal anti-HIV drug delivery.
    Blakney AK; Ball C; Krogstad EA; Woodrow KA
    Antiviral Res; 2013 Dec; 100 Suppl():S9-16. PubMed ID: 24188701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and preliminary safety study of pod-intravaginal rings delivering antiretroviral combinations for HIV prophylaxis in a macaque model.
    Moss JA; Srinivasan P; Smith TJ; Butkyavichene I; Lopez G; Brooks AA; Martin A; Dinh CT; Smith JM; Baum MM
    Antimicrob Agents Chemother; 2014 Sep; 58(9):5125-35. PubMed ID: 24936594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vaginal deployment and tenofovir delivery by microbicide gels.
    Gao Y; Yuan A; Chuchuen O; Ham A; Yang KH; Katz DF
    Drug Deliv Transl Res; 2015 Jun; 5(3):279-94. PubMed ID: 25874971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 90-day tenofovir reservoir intravaginal ring for mucosal HIV prophylaxis.
    Johnson TJ; Clark MR; Albright TH; Nebeker JS; Tuitupou AL; Clark JT; Fabian J; McCabe RT; Chandra N; Doncel GF; Friend DR; Kiser PF
    Antimicrob Agents Chemother; 2012 Dec; 56(12):6272-83. PubMed ID: 23006751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. pH-responsive nanoparticles releasing tenofovir intended for the prevention of HIV transmission.
    Zhang T; Sturgis TF; Youan BB
    Eur J Pharm Biopharm; 2011 Nov; 79(3):526-36. PubMed ID: 21736940
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of tenofovir-UC781 combination microbicide vaginal gels.
    Kiser PF; Mahalingam A; Fabian J; Smith E; Damian FR; Peters JJ; Katz DF; Elgendy H; Clark MR; Friend DR
    J Pharm Sci; 2012 May; 101(5):1852-64. PubMed ID: 22359356
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete protection from repeated vaginal simian-human immunodeficiency virus exposures in macaques by a topical gel containing tenofovir alone or with emtricitabine.
    Parikh UM; Dobard C; Sharma S; Cong ME; Jia H; Martin A; Pau CP; Hanson DL; Guenthner P; Smith J; Kersh E; Garcia-Lerma JG; Novembre FJ; Otten R; Folks T; Heneine W
    J Virol; 2009 Oct; 83(20):10358-65. PubMed ID: 19656878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel approaches to vaginal delivery and safety of microbicides: biopharmaceuticals, nanoparticles, and vaccines.
    Whaley KJ; Hanes J; Shattock R; Cone RA; Friend DR
    Antiviral Res; 2010 Dec; 88 Suppl 1():S55-66. PubMed ID: 21109069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An intravaginal ring for the simultaneous delivery of multiple drugs.
    Baum MM; Butkyavichene I; Gilman J; Kennedy S; Kopin E; Malone AM; Nguyen C; Smith TJ; Friend DR; Clark MR; Moss JA
    J Pharm Sci; 2012 Aug; 101(8):2833-43. PubMed ID: 22619076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Natural substrate concentrations can modulate the prophylactic efficacy of nucleotide HIV reverse transcriptase inhibitors.
    García-Lerma JG; Aung W; Cong ME; Zheng Q; Youngpairoj AS; Mitchell J; Holder A; Martin A; Kuklenyik S; Luo W; Lin CY; Hanson DL; Kersh E; Pau CP; Ray AS; Rooney JF; Lee WA; Heneine W
    J Virol; 2011 Jul; 85(13):6610-7. PubMed ID: 21525346
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.